This is a summary of the European public assessment report (EPAR). It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the studies performed, to reach their recommendations on how to use the medicine. If you need more information about your medical condition or your treatment, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist. If you want more information on the basis of the CHMP recommendations, read the scientific discussion (also part of the EPAR).
Therapeutic Indication
### Therapeutic indication Twinrix Adult is indicated for use in non immune adults and adolescents 16 years of age and above who are at risk of both hepatitis A and hepatitis B infection.
Therapeutic Area (MeSH)
N/AATC Code
J07BC20
ATC Item
combinations
Pharmacotherapeutic Group
Vaccines
Active Substance (Summary)
N/AINN / Common Names
N/A| Substance | CAS | Monograph |
|---|---|---|
| hepatitis A virus (inactivated) | N/A | hepatitis a virus (inactivated) |
| hepatitis B surface antigen | N/A | 乙型肝炎病毒表面抗原 |
EMA Name
Twinrix Adult
Medicine Name
Twinrix Adult
Aliases
N/ANo risk management plan link.